Sofinnova Venture Partners Viii, L.P. Insider Profile
4 Followers
Sofinnova Venture Partners Viii, L.P., Ten Percent Owner at Ocugen, holds 2.04M shares in Principia Biopharma (Ticker: PRNB), holds 2.08M shares in Ocugen (Ticker: OCGN).
Sofinnova Venture Partners Viii, L.P.'s Trading History
| PRNBPrincipia Biopharma | Sep 20, 2018 | ― | Uninformative Buy | ― | $203.92M | |
| OCGNOcugen | Dec 10, 2014 | Ten Percent Owner | Uninformative Sell | 11.02K | $1.72M |
You May Also Like
Sofinnova Venture Partners Viii, L.P. insider profile FAQ
What is the percentage of profitable transactions made by Sofinnova Venture Partners Viii, L.P.?
The percentage of profitable transactions made by Sofinnova Venture Partners Viii, L.P. is 50%.
What is the average return per transaction made by Sofinnova Venture Partners Viii, L.P.?
The average return per transaction made by Sofinnova Venture Partners Viii, L.P. is -27.30%.
What stocks does Sofinnova Venture Partners Viii, L.P. hold?
Sofinnova Venture Partners Viii, L.P. holds: OCGN, PRNB stocks.
What was Sofinnova Venture Partners Viii, L.P.'s most profitable transaction?
Sofinnova Venture Partners Viii, L.P.’s most profitable transaction was an Informative Buy of PRNB stock on September 20, 2018. The return on the trade was 17.80%.
What is Sofinnova Venture Partners Viii, L.P.'s role in Ocugen?
Sofinnova Venture Partners Viii, L.P.'s role in Ocugen is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
